Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genescience Pharmaceuticals (GenSci) is a leading Chinese biopharmaceutical company specializing in the development, manufacturing, and commercialization of recombinant human growth hormones and other therapeutic proteins. Established in 1996, the company is best known for its flagship product, Jintropin, which was the first recombinant human growth hormone (rhGH) produced in China. GenSci operates extensive R&D and manufacturing facilities, focusing on endocrinology, assisted reproduction, and oncology. While headquartered in Changchun, China, the company maintains a presence in North America through its subsidiary, North America Genescience, to facilitate international R&D collaborations and clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North America Genescience.